Daniel F. Heitjan

Daniel F. Heitjan's AcademicInfluence.com Rankings

Daniel F. Heitjan

Mathematics

#7280

World Rank

#9923

Historical Rank

#2038

USA Rank

Statistics

#809

World Rank

#897

Historical Rank

#178

USA Rank

mathematics Degrees

Download Badge

Mathematics

Daniel F. Heitjan's Degrees

PhD Biostatistics University of Washington
Masters Biostatistics University of Washington
Bachelors Mathematics University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Math 2025

Why Is Daniel F. Heitjan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daniel F. Heitjan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Long-term use of a left ventricular assist device for end-stage heart failure. (2001) (3420)
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains (2009) (772)
Ignorability and Coarse Data (1991) (602)
Hyperuricemia and coronary heart disease: A systematic review and meta‐analysis (2010) (601)
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. (1999) (541)
Hyperuricemia and risk of stroke: a systematic review and meta-analysis. (2009) (437)
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme (2014) (414)
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. (1999) (349)
Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. (1995) (321)
Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer. (1999) (319)
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma (2014) (311)
Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. (1996) (310)
CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment (2014) (302)
Mixed-effects models in psychophysiology. (2000) (297)
Carbon dioxide protects the perinatal brain from hypoxic-ischemic damage: an experimental study in the immature rat. (1995) (258)
Distinguishing “Missing at Random” and “Missing Completely at Random” (1996) (255)
Combined autophagy and proteasome inhibition (2014) (244)
Measuring agreement in medical informatics reliability studies (2002) (228)
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. (2015) (222)
Multiple Imputation for the Fatal Accident Reporting System (1991) (222)
Survival Associated with 5-FluorouracilBased Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer (2002) (219)
Combined MTOR and autophagy inhibition (2014) (199)
Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program. (2014) (193)
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. (2012) (191)
Inference from Coarse Data via Multiple Imputation with Application to Age Heaping (1990) (191)
Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder ★ (2011) (180)
Allopurinol Administered after Inducing Hypoxia-Ischemia Reduces Brain Injury in 7-Day-Old Rats (1993) (172)
Cost-Effectiveness of Preventive Strategies for Women with a BRCA1 or a BRCA2 Mutation (2006) (165)
Rapid reduction in blood flow to the rat ventral prostate gland after castration: Preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival (1998) (164)
CCL2 blockade augments cancer immunotherapy. (2010) (164)
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. (2002) (159)
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. (2002) (155)
Volume-outcome relationships in cardiovascular operations: New York State, 1990-1995. (1999) (149)
A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses (2007) (145)
Inference from Grouped Continuous Data: A Review (1989) (142)
Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis. (1999) (134)
Wound complications of autogenous subcutaneous infrainguinal arterial bypass surgery: predisposing factors and management. (1990) (130)
Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders. (1988) (128)
Multiple Imputation for Model Checking: Completed‐Data Plots with Missing and Latent Data (2005) (125)
Effect of Insulin-Induced and Fasting Hypoglycemia on Perinatal Hypoxic-Ischemic Brain Damage (1992) (125)
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder (2015) (123)
Intraoperative near-infrared imaging can identify pulmonary nodules. (2014) (122)
AN INDEX OF LOCAL SENSITIVITY TO NONIGNORABILITY (2004) (110)
Annotation: what can be done about missing data? Approaches to imputation. (1997) (107)
A Phase I Trial of Repeated Intrapleural Adenoviral-mediated Interferon-β Gene Transfer for Mesothelioma and Metastatic Pleural Effusions. (2010) (106)
Ignorability in general incomplete-data models (1994) (104)
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers (2011) (102)
Bayesian interim analysis of phase II cancer clinical trials. (1997) (101)
Bayesian estimation of cost-effectiveness ratios from clinical trials. (1999) (99)
Ignorability and coarse data: some biomedical examples. (1993) (99)
Reproducibility of the Nicotine Metabolite Ratio in Cigarette Smokers (2012) (95)
Early effects of castration on the vascular system of the rat ventral prostate gland. (1999) (89)
Effectiveness of Extended-Duration Transdermal Nicotine Therapy (2010) (89)
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma. (2011) (88)
Modeling heaping in self‐reported cigarette counts (2008) (87)
Urinary continence after radical prostatectomy: the Columbia experience. (1998) (86)
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. (2010) (86)
Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers (2008) (84)
Statistical analysis of in vivo tumor growth experiments. (1993) (79)
Geographic variations in the rates of operative procedures involving the shoulder, including total shoulder replacement, humeral head replacement, and rotator cuff repair. (1999) (78)
Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2. (1999) (78)
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. (2002) (76)
Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resection. (2015) (75)
An index of local sensitivity to nonignorable drop‐out in longitudinal modelling (2005) (73)
A predictive model for the detection of tumor lysis syndrome during AML induction therapy (2006) (73)
Gemcitabine for relapsed or resistant lymphoma. (2000) (73)
Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells. (1987) (72)
Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis. (2000) (70)
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients (2013) (70)
Fieller's method and net health benefits. (2000) (69)
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy (2016) (63)
The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas. (2015) (62)
Research Paper: A Reliability Study for Evaluating Information Extraction from Radiology Reports (1999) (62)
Effect of unilateral perinatal hypoxic-ischemic brain damage on the gross development of opposite cerebral hemisphere. (1994) (61)
Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin (2015) (60)
Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. (1994) (58)
Pretreatment prostate specific antigen doubling times: use in patients before radical prostatectomy. (1997) (58)
HPV‐related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery (2016) (58)
Review Paper: Design and Analysis of Controlled Trials in Naturally Clustered Environments: Implications for Medical Informatics (2002) (58)
Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score–Matched Analysis (2018) (57)
Comparison between the analgesic efficacy of transversus abdominis plane (TAP) block and placebo in open retropubic radical prostatectomy: a prospective, randomized, double-blinded study. (2013) (56)
Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study (2007) (54)
DNA methylation profiling of cervical squamous intraepithelial lesions using liquid‐based cytology specimens (2004) (54)
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. (2011) (48)
Dietary flaxseed administered post thoracic radiation treatment improves survival and mitigates radiation-induced pneumonopathy in mice (2011) (48)
Effect of Status Epilepticus on Hypoxic-Ischemic Brain Damage in the Immature Rat (1995) (48)
Problems with Interval Estimates of the Incremental Cost—Effectiveness Ratio (1999) (47)
Testing and Adjusting for Departures from Nominal Dispersion in Generalized Linear Models (1993) (45)
Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase‐polymerase chain reaction assay in patients with early stage prostate carcinoma (1997) (45)
High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT (2012) (45)
Allopurinol preserves cerebral energy metabolism during perinatal hypoxia-ischemia: A 31P NMR study in unanesthetized immature rats (1992) (44)
Identification of pharmacogenetic markers in smoking cessation therapy (2008) (44)
Association of HLA Polymorphisms with Post‐transplant Lymphoproliferative Disorder in Solid‐Organ Transplant Recipients (2011) (44)
Modeling of the Growth Kinetics of Occult Breast Tumors: Role in Interpretation of Studies of Prevention and Menopausal Hormone Therapy (2012) (43)
Generalized Norton-Simon models of tumour growth. (1991) (43)
A Simple Local Sensitivity Analysis Tool for Nonignorable Coarsening: Application to Dependent Censoring (2006) (43)
Convergent Evidence that Choline Acetyltransferase Gene Variation is Associated with Prospective Smoking Cessation and Nicotine Dependence (2010) (41)
31P and 1H MRS of DB‐1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan (2013) (40)
DNA Methylation in Anal Intraepithelial Lesions and Anal Squamous Cell Carcinoma (2005) (40)
Predicting analysis times in randomized clinical trials (2001) (39)
Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking (2015) (38)
In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic cells. (1987) (37)
Sensitivity analysis of causal inference in a clinical trial subject to crossover (2004) (36)
Decision analysis of tamoxifen for the prevention of invasive breast cancer. (2000) (35)
A placebo-controlled trial of modafinil for nicotine dependence. (2008) (34)
The effect of focal cerebral cooling on perinatal hypoxic-ischemic brain damage (1994) (34)
Using a state cancer registry to increase screening behaviors of sisters and daughters of breast cancer patients. (1991) (34)
Assessing the fit of parametric cure models. (2013) (33)
Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter. (1996) (33)
Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial. (2016) (32)
Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic Leukemia (2003) (31)
Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support. (1997) (31)
Assessing Secular Trends in Blood Pressure: A Multiple-Imputation Approach (1994) (31)
Real-time prediction of clinical trial enrollment and event counts: A review. (2015) (31)
Elevation in serum lactate at the time of Febrile Neutropenia (FN) in hemodynamically-stable patients with Hematologic Malignancies (HM) is associated with the development of septic shock within 48 hours (2010) (31)
Weibull prediction of event times in clinical trials (2008) (30)
A method comparison study of timeline followback and ecological momentary assessment of daily cigarette consumption. (2009) (30)
Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer. (1998) (30)
Treatment of head and neck cancer. (1998) (30)
Causal inference in a clinical trial: a comparative example. (1999) (30)
Effects of menopausal hormonal therapy on occult breast tumors (2013) (29)
Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase. (1998) (29)
Ignorability, Sufficiency and Ancillarity (1997) (29)
Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy. (1998) (29)
Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity. (1998) (29)
Impact of nonignorable coarsening on Bayesian inference. (2006) (28)
Modelling repeated-series longitudinal data. (1997) (28)
Nonparametric prediction of event times in randomized clinical trials (2004) (27)
Truth and Memory: Linking Instantaneous and Retrospective Self-Reported Cigarette Consumption. (2013) (27)
Nonlinear Modeling of Serial Immunologic Data: A Case Study (1991) (27)
An Active Learning Approach for Rapid Characterization of Endothelial Cells in Human Tumors (2014) (26)
Nonignorable censoring in randomized clinical trials (2005) (26)
Missing Data in Model‐Based Pharmacometric Applications: Points to Consider (2010) (25)
Bayesian estimation of cost‐effectiveness from censored data (2004) (25)
Occult Breast Tumor Reservoir: Biological Properties and Clinical Significance (2013) (24)
Ignorability and bias in clinical trials. (1999) (24)
Phenotypic features of breast cancer cells overexpressing ornithine‐decarboxylase (1995) (24)
Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression (1989) (24)
MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib. (2013) (23)
31P NMR spectroscopy of perinatal hypoxic‐ischemic brain damage: A model to evaluate neuroprotective drugs in immature rats (1992) (22)
A phase I trial of palbociclib and paclitaxel in metastatic breast cancer. (2014) (19)
Estimating the effect of an intensive surveillance program on stage of breast carcinoma at diagnosis (2001) (19)
Predicting Event Times in Clinical Trials When Treatment Arm Is Masked (2006) (19)
High-dose chemotherapy for breast cancer. (1999) (19)
Effects of hyperglycemia on lonidamine‐induced acidification and de‐energization of human melanoma xenografts and sensitization to melphalan (2015) (18)
Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers. (2015) (17)
Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions. (2012) (17)
A phase II trial of an oral CDK 4/6 inhibitor, PD0332991, in advanced breast cancer. (2013) (17)
Modeling smoking cessation data with alternating states and a cure fraction using frailty models (2010) (17)
Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids (2018) (17)
Bayesian estimation of cost-effectiveness: an importance-sampling approach. (2004) (17)
Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancer. (1991) (15)
Multiplicity-calibrated Bayesian hypothesis tests. (2010) (15)
Phase II trial of the autophagy inhibitor hydroxychloroquine with FOLFOX and bevacizumab in front line treatment of metastatic colorectal cancer. (2017) (15)
Underlying breast cancer risk and menopausal hormone therapy. (2020) (15)
Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer. (2001) (15)
Local Sensitivity to Nonignorability: Dependence on the Assumed Dropout Mechanism (2009) (15)
Incomplete Data: What You Don't Know Might Hurt You (2011) (14)
Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer (2013) (14)
Statistical modeling and prediction of clinical trial recruitment (2018) (14)
Metaiodobenzylguanidine and Hyperglycemia Augment Tumor Response to Isolated Limb Perfusion in a Rodent Model of Human Melanoma (2004) (13)
Regression with bivariate grouped data. (1991) (13)
Differences in Intraischemic Temperature Influence Neurological Outcome After Deep Hypothermic Circulatory Arrest in Newborn Dogs (1994) (13)
EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT. (2013) (12)
Predicting event times in clinical trials when randomization is masked and blocked (2007) (12)
Effect of Hypoxia/Ischemia on Bicuculline‐Induced Seizures in Immature Rats: Behavioral and Electrocortical Phenomena (1995) (12)
Biology, Models, and the Analysis of Tumor Xenograft Experiments (2011) (12)
A decision-theoretic evaluation of early stopping rules. (1992) (12)
PROBABILISTIC SENSITIVITY ANALYSIS IN COST-EFFECTIVENESS (1999) (12)
Biologic classification as an alternative to anatomic staging for clinically localized prostate cancer: a proposal based on patients treated with external beam radiotherapy. (1998) (11)
Measuring the Impact of Nonignorable Missingness Using the R Package isni (2018) (10)
Phase II trial of autophagy inhibition using hydroxychloroquine (HCQ) with FOLFOX/bevacizumab in the first-line treatment of advanced colorectal cancer. (2015) (10)
Systolic thickening increases from subepicardium to subendocardium. (1990) (9)
Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known? (2008) (9)
Acute changes in cellular-interstitial water exchange rate in DB-1 Melanoma xenografts after lonidamine administration as a marker of tumor energetics and ion transport (2013) (9)
Prediction of Individual Long‐term Outcomes in Smoking Cessation Trials Using Frailty Models (2011) (8)
Comparison Between the Analgesic Efficacy of Transversus Abdominis Plane (TAP) Block and Placebo in Open Retropubic Radical Prostatectomy: A Prospective, Randomized, Double-Blinded Study (2014) (8)
Prediction of event times in the REMATCH Trial (2013) (8)
PSA-Net: Deep Learning based Physician Style-Aware Segmentation Network for Post-Operative Prostate Cancer Clinical Target Volume (2021) (8)
Ascertainment and Anticipation in Family Studies (2000) (8)
COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans (2021) (8)
The multi‐site tumour transplantation model for human endometrial carcinoma: a statistical evaluation (1992) (8)
Survival of women diagnosed with breast cancer and who have survived a previous cancer (2021) (7)
Estimating lead‐time bias in lung cancer diagnosis of patients with previous cancers (2018) (7)
Suppression of β-Catenin by Antisense Oligomers Augments Tumor Response to Isolated Limb Perfusion in a Rodent Model of Adenomatous Polyposis Coli–Mutant Colon Cancer (2005) (7)
Serum Lactic Acid (LA) as a Predictor of Septic Shock in Patients with Hematologic Malignancies (HM) Who Develop Febrile Neutropenia (2008) (7)
Statistical justification of expansion cohorts in phase 1 cancer trials (2018) (7)
Reduction of Immunosuppression as Initial Therapy for Post-Transplantation Lymphoproliferative Disorder: Analysis of Efficacy, Safety and Prognostic Factors. (2009) (6)
A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials (2012) (6)
Missing Data in Longitudinal Studies: Strategies for Bayesian Modeling and Sensitivity Analysis by DANIELS, M. J. and HOGAN, J. W (2009) (6)
Phase 1 trial of gemcitabine/nab-paclitaxel in combination with the autophagy inhibitor hydroxychloroquine in previously untreated patients with metastatic pancreatic adenocarcinoma. (2015) (5)
Estimating cost-effectiveness from claims and registry data with measured and unmeasured confounders (2019) (5)
Statistical analysis of daily smoking status in smoking cessation clinical trials. (2011) (5)
Sensitivity of the discrete‐time Kaplan–Meier estimate to nonignorable censoring: Application in a clinical trial (2012) (5)
Interim results of a phase 1b/2a study evaluating the nano pharmaceutical CRLX101 with bevacizumab (bev) in the treatment of patients (pts) with refractory metastatic renal cell carcinoma (mRCC). (2014) (5)
Proximity and gravity: modeling heaped self‐reports (2017) (4)
γ-Interferon-induced monocyte major histocompatibility complex class II antigen expression in individuals with acquired immune deficiency syndrome (1989) (4)
Sensitivity to Nonignorability in Frequentist Inference (2005) (4)
Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin (2018) (4)
Cure modeling in real-time prediction: How much does it help? (2017) (4)
Suspension of accrual in phase II cancer clinical trials (2015) (4)
Androgen-primed chemotherapy—Experimental confirmation of efficacy (1990) (4)
Commentary on Mason et al. (2017) (4)
Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study (2011) (4)
A pattern‐mixture model for the analysis of censored quality‐of‐life data (2006) (4)
Adaptive parametric prediction of event times in clinical trials (2018) (3)
Abstract P2-16-20: Biomarkers to predict response to the CDK 4/6 inhibitor, palbociclib (PD 0332991) in a single-agent phase II trial in advanced breast cancer (2013) (3)
Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer (2021) (3)
Book Review: The EM Algorithm and Extensions. Geoffrey J. McLachlan and Thriyambakam Krishnan, Wiley, New York, 1997. No. of pages: xvii+274. Price: $59.95. ISBN 0-471-12358-7 (1998) (2)
Evaluation of physician knowledge and referral practices for colorectal cancer (CRC) genetic risk assessment: The experience at the Hospital of University of Pennsylvania (HUP). (2011) (2)
Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist (2010) (2)
Bayesian Analysis of a Protocol for Sampling Preserved Tumor Specimens (1995) (2)
Survival of cancer survivors with a new pancreatic cancer diagnosis (2022) (2)
Reproducibility of the Penn predictive score of tumor lysis syndrome (PPS-TLS) in acute myelogenous leukemia (AML). (2006) (2)
[Inference from Grouped Continuous Data: A Review]: Rejoinder (1989) (2)
Systemic Inflammatory Response Syndrome (SIRS) as Predictor of Severe Sepsis (SS) in Hospitalized Patients (pts) with Hematologic Malignancies. (2007) (1)
Estimating the optimal timing of surgery from observational data (2020) (1)
Generalizing Clinical Trial Results to a Target Population (2021) (1)
Clinical cancer monographs. Vol. 2: Cancer of the larynx. Peter E. Robin, Jean Powell, Guy M. Holme el al., Macmillan Press, London, 1989. No. of pages: 238. Price: £D40 (1990) (1)
A Note on the Complementary Mixture Pareto II Distribution (2013) (1)
Comparative effectiveness of screening, surgery, and chemoprevention among BRCA1/2 mutation carriers. (2010) (1)
Feasibility, Safety and Efficacy of Maraviroc, a CCR5 Antagonist, in Graft-Versus-Host Disease Prevention After Reduced intensity Conditioned (RIC) Allogeneic Stem Cell Transplant (SCT): a Phase I/II Study (2011) (1)
Sensitivity analysis for incomplete data via unmeasured confounding (2023) (1)
Flexible, rule-based dose escalation: The cohort-sequence design (2020) (1)
Time until first significant difference in in vivo tumor growth experiments. (1995) (1)
Dietary Flaxseed Administered Post Thoracic Radiation Exposure Improves Survival And Mitigates Radiation-Induced Pneumonopathy In Mice (2011) (1)
Phase II trial of anti-transforming growth factor-beta (TGFß) monoclonal antibody GC1008 in relapsed malignant pleural mesothelioma (MPM). (2012) (1)
Approach to Managing a Postmenopausal Patient. (2020) (1)
Prevalence of Hepatitis C Virus Antibody in Patients With Sexually Transmitted Diseases Attending a Harrisburg, PA, STD Clinic (1994) (1)
A Predictive Model for Tumor Lysis Syndrome in Acute Myelogenous Leukemia. (2004) (1)
Authors' Reply (0)
Observational Studies (Paul R. Rosenbaum. Springer-Verlag) (1996) (0)
The Optical Biopsy: A Novel Technique for Rapid Intraoperative onary Adenocarcinomas Diagnosis of Primary Pulm (2015) (0)
Abstract PS11-31: Survival among female breast cancer patients who have survived a previous cancer (2021) (0)
Book Reviews (2016) (0)
Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin (2018) (0)
The NSABP trials. (1994) (0)
Model‐based imputation of latent cigarette counts using data from a calibration study (2016) (0)
Sensitivity Analysis for Incomplete Data and Causal Inference Sensitivity Analysis for Incomplete Data and Causal Inference SENSITIVITY ANALYSIS FOR INCOMPLETE DATA AND CAUSAL INFERENCE SENSITIVITY ANALYSIS FOR INCOMPLETE DATA AND CAUSAL INFERENCE Sensitivity Analysis for Incomplete Data and Causal (2020) (0)
Ignorability conditions for frequentist non parametric analysis of conditional distributions with incomplete data (2017) (0)
Neurocognitive Issues in Off-Pump CABG (2004) (0)
Survival among breast cancer patients with a history of previous cancer. (2020) (0)
Regional Anesthesia and Pain Control Comparison Between the Analgesic Efficacy of Transversus Abdominis Plane (TAP) Block and Placebo in Open Retropubic Radical Prostatectomy: A Prospective, Randomized, Double-Blinded Study (2014) (0)
and mitigates radiation-induced pneumonopathy in mice (2011) (0)
A PILOT AND FEASIBILITY CLINICAL TRIAL EVALUATING IMMUNO-GENE THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA (Ad.hIFN-α2b) IN COMBINATION WITH HIGH-DOSE CELECOXIB AND SYSTEMIC CHEMOTHERAPY (2016) (0)
2583 pH-sensitive nanoparticle for delivery of lonidamine to triple-negative breast cancer : A preliminary 31 P MRS study (2013) (0)
Inhibition of CDC2 and CDK2 and radiosensitization of human glioblastoma cells by the staurosporine derivative CGP 41251 (1996) (0)
UQ-ARMED: Uncertainty quantification of adversarially-regularized mixed effects deep learning for clustered non-iid data (2022) (0)
Exact Inference for Meta-Analysis of Rare Events and Its Application in Human Genetics (2022) (0)
Nonparametric estimation of a heaping mechanism for precise and heaped self-report data (2011) (0)
Title : Projecting survival and lifetime costs from short-term smoking cessation trials (2016) (0)
Selective acidification and de-energization of A 2780 ovarian cancer xenografts using lonidamine : A preliminary 1 H and 31 P MRS study (2013) (0)
Sheppard's Corrections (2005) (0)
Missing Data, Types of (2014) (0)
Gamma-interferon-induced monocyte major histocompatibility complex class II antigen expression individuals with acquired immune deficiency syndrome. (1989) (0)
Editorial: Clinical trial design in the era of COVID-19 (2020) (0)
In situ quantification of aberrant p53 in colorectal neoplasia (2003) (0)
Erratum: Sensitivity analysis of causal inference in a clinical trial subject to crossover. (Clinical Trials 1 (22-30)) (2005) (0)
A Predictive Model for Cytogenetic Risk Group in Elderly AML: The Penn Cytogenetic Surrogate Score (PCSS). (2006) (0)
Correction: CCL2 Blockade Augments Cancer Immunotherapy (2010) (0)
Medical Decision Making and MDM Policy & Practice Reviewers, 2018. (2019) (0)
Survival among colorectal cancer patients with a history of previous cancer. (2020) (0)
Sheppard's Corrections† (2014) (0)
Prognostic value of the maximum standardized uptake value of staging FDG-PET/CT in Hodgkin lymphoma. (2014) (0)
Medical Decision Making and MDM Policy & Practice Reviewers, 2018. (2019) (0)
Phase I T rial o f D ocetaxel W ith E stramustine in A ndrogen-Indepen dent P rostate C ancer (1999) (0)
Lonidamine reverses the cell membrane pH gradient of human DB-1 melanoma xenografts (2011) (0)
Estimating the optimal timing of surgery by imputing potential outcomes (2021) (0)
Abstract B56: An immuno-gene therapy clinical trial evaluating in situ vaccination of malignant pleural mesothelioma with intrapleural delivery of adenovirus-interferon-alpha-2b in combination with chemotherapy (2015) (0)
Summer 8-6-2019 Clinical Trial Design and Analysis (2019) (0)
DECREASING FALSE POSITIVE URINE RESULTS: THE UTILITY OF A MIDSTREAM CATHETERIZED SPECIMEN (1997) (0)
Guest Editor: Thomas R. Ten Have, Ph.D., M.P.H. (1958–2011) (2011) (0)
Single-Dose Intrapleural IFN-B GeneTransfer forMalignant PleuralMesotheliomaandMetastatic Pleural Effusions : HighRate ofAntitumor ImmuneResponses (2007) (0)
Analysis of local sensitivity to nonignorability with missing outcomes and predictors (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Daniel F. Heitjan?

Daniel F. Heitjan is affiliated with the following schools:

Daniel F. Heitjan's Academic­Influence.com Rankings